Functional consequences of angiotensin-converting enzyme gene polymorphism on N-acetyl-Ser-Asp-Lys-Pro degradation and angiotensin II production

Journal of Molecular Medicine

Volumn 80, Issue 8, 2002, Pages 492-498

  Azizi, Michel ^a   Junot, Christophe ^b   Ezan, Eric ^b   Hallouin, Marie Charlotte ^a   Guyene, Than ^a   Ménard, Joël ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b CEA SACLAY   (France)

Author keywords

Angiotensin; Genetics; Metabolism; Peptides; Peptidyl dipeptidase A

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN I; BRADYKININ; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; LOSARTAN; PEPTIDE HORMONE; SERASPENIDE;

ADULT; ARTICLE; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG INFUSION; DRUG METABOLISM; ENZYME INHIBITION; ENZYME METABOLISM; ENZYME POLYMORPHISM; GENE DELETION; GENE INSERTION; GENE INSERTION SEQUENCE; HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; MALE; QUANTITATIVE ANALYSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ADOLESCENT; ADULT; ANGIOTENSIN I; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CAPTOPRIL; CROSS-OVER STUDIES; FEMALE; GENOTYPE; HOMOZYGOTE; HUMANS; MALE; OLIGOPEPTIDES; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; SINGLE-BLIND METHOD; SUBSTRATE SPECIFICITY;

EID: 0036375404     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-002-0357-z     Document Type: Article

References (28)

1. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels
2. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1)
3. Angiotensin I-converting enzyme in human circulating mononuclear cells: Genetic polymorphism of expression in T-lymphocytes
4. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction
5. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk
6. Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls
7. Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects
8. Pressor and hormonal responses to angiotensin I infusion in healthy subjects of different angiotensin-converting enzyme genotypes
9. Angiotensin I to angiotensin II conversion in the human forearm and leg. Effect of the angiotensin converting enzyme gene insertion/deletion polymorphism
10. Human vascular reactivity and polymorphisms of the angiotensin-converting enzyme and the angiotensin type 1 receptor genes
11. The angiotensin-converting enzyme gene polymorphism and responses to angiotensins and bradykinin in the human forearm
12. No relation between angiotensin-converting enzyme gene polymorphism and dermal response to bradykinin in healthy subjects
13. Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme
14. The deletion polymorphism of the angiotensin-converting enzyme gene is related to phenotypic differences in human arteries
15. ACE (I/D) genotype as a predictor of the magnitude and duration of the response to an ACE inhibitor drug (enalaprilat) in humans
16. Angiotensin-converting enzyme insertion/deletion polymorphism modulates the human in vivo metabolism of bradykinin
17. Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysylproline
18. Metabolism and production of angiotensin I in different vascular beds in subjects with hypertension
19. Role of renal endopeptidase 24.11 in kinin metabolism in vitro and in vivo
20. Renal and metabolic clearance of AcSDKP during angiotensin converting enzyme inhibition in humans
21. The hemoregulatory peptide N-Acetyl-Ser-Asp-Lys-Pro (NAc-SDKP) impairs angiotensin I contraction in rat aorta
22. Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition
23. Relation between changes in blood pressure and serum ACE activity after a single dose of enalapril and ACE genotype in healthy subjects
24. Regional angiotensin II production in essential hypertension and renal artery stenosis
25. Angiotensinogen (M235T) and angiotensin-converting enzyme (I/D) polymorphisms in association with plasma renin and prorenin levels
26. The deletion genotype of the angiotensin I-converting enzyme is associated with an increased vascular reactivity in vivo and in vitro
27. DD angiotensin-converting enzyme gene polymorphism is associated with endothelial dysfunction in normal humans
28. Accurate assessment of precision errors: How to measure the reproducibility of bone densitometry techniques